Clinical trial
A Comparative, Randomized, Double-blind, 3-arm Parallel, Phase III Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Nefopam/Paracetamol Taken Orally in Moderate to Severe Pain After Impacted Third Molar Extraction
NCT04622735 is registered in ClinicalTrials.gov with Unither Pharmaceuticals, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative, Randomized, Double-blind, 3-arm Parallel, Phase III Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Nefopam/Paracetamol Taken Orally in Moderate to Severe Pain After Impacted Third Molar Extraction
- Lead sponsor
- Unither Pharmaceuticals, France
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 22, 2020
- Completion date
- October 20, 2022
- Enrollment
- 321 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.